Colon cancer blood test offers new screening option
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Related articles
Horoscope today: Daily guide to what the stars have in store for YOU
'Shinrin-Yoku' is the Japanese term for a 'forest bath'. It's the practice of immersing in nature as2024-05-01- A first half goal from Arda Guler saw Real Madrid win 1-0 away to Real Sociedad to move another step2024-05-01
Teenage golfer Ji wins first pro title in Tianjin
China's 19-year-old golfer Ji Yuai captured her first pro title on Saturday, carding a final-rou2024-05-01Brendan Steele wins LIV Golf Adelaide tournament from fast
ADELAIDE, Australia (AP) — Three-time PGA Tour winner Brendan Steele held off a fast finishing Louis2024-05-01Astros promote 1B prospect Loperfido as Abreu's struggles continue for slumping team
HOUSTON (AP) — The Houston Astros are promoting first baseman Joey Loperfido from Triple-A Sugar Lan2024-05-01Benteke scores 2 more goals as DC United beats short
WASHINGTON (AP) — Christian Benteke scored two goals, Alex Bono had four saves and D.C. United ralli2024-05-01
atest comment